Amplia Therapeutics Ltd

(INNMF)

Symbol has changed to a new ticker symbol

(ATX:AU)

By |

Profile

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Contact Information

Website: www.ampliatx.com
Main Phone: +61 280033650
Address: 55 Flemington Road
Address 2: Suite 226
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3051

Issuer Information

Exchange: OTO


Gathering Data... Please wait

Profile

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Contact Information

Website: www.ampliatx.com
Main Phone: +61 280033650
Address: 55 Flemington Road
Address 2: Suite 226
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3051

Issuer Information

Exchange: OTO
$ 0.0969 $ -0.0071 (-6.83%)
Last Price 0.0969 Change $ -0.0071 Change % -6.83 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0969 High 0.0969 Low 0.0969 Prev Close 0.10
Last Trade Volume 838 52 Wk Hi 0.41 52 Wk Low 0.02
Market Cap 4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,023,303.00 EPS (TTM) -0.07 PE Ratio N/A Exchange OTCPK